
Nasim Parsa, M.D.
@nasimparsamd
Director of Digital Health & Innovation, Co-Director of Esophageal Diseases Program @UMN_GIHEP | Co-editor: #AI in Clinical Medicine ๐| @MayoClinic Alumna
ID: 3046135234
https://scholar.google.com/citations?user=YWaeaTkAAAAJ&hl=en 20-02-2015 08:26:00
629 Tweet
1,1K Followers
630 Following


Great lecture by new GI & Hepatology Division - University of Minnesota faculty member Dr. Nasim Parsa ( Nasim Parsa, M.D.)! ๐๐

We are thrilled to welcome Dr. Nasim Parsa (Nasim Parsa, M.D.) to GI & Hepatology Division - University of Minnesota! Dr. Parsa specializes in esophageal disorders and has academic interests in endoscopic innovations and medical artificial intelligence.


๐Excited to start this new chapter as Director of Digital Health & Innovation & Co-Director of Esophageal Disorders Program at GI & Hepatology Division - University of Minnesota A heartfelt ๐ to the incredible leadership Stuart K. Amateau, MD PhD for this opportunity & to my mentors who have supported me throughout my journey

๐จ ๐จ ๐จ Join us this Feb 28 & Mar 1st for the 5th Caribbean Congress on Therapeutic Endoscopy. I will be presenting on the role of #ArtificialIntelligence in #IBD ! Great content & amazing speakers๐ Carlos Micames Neil Sharma, M.D. FASGE, FACG, AGAF Roberto Simons-Linares, MD Olaya Brewer-Gutierrez, MD Frank G Gress MD MBA


5th Caribbean Congress on Therapeutic Endoscopy! It was a great honor to be part of the faculty & to speak on one of my favorite topics: #AI in #IBD Many thanks to Carlos Micames & his great team in San Juan ๐๏ธ Neil Sharma, M.D. FASGE, FACG, AGAF Dr. Amrita Sethi GI & Hepatology Division - University of Minnesota Satisfai Health Inc my_UEG



๐๏ธ Excited to moderate the upcoming ASGE GI Endoscopy session at Digestive Disease Week on #POEM with an outstanding faculty panel! We'll explore 15-yr outcome data, technical innovations & novel diagnostic/therapeutic applications to improve outcomes! Join us to discuss the future of POEM!




#AI is reshaping #IBD care, from diagnosis to personalized therapy. Our review explores innovation in AI-powered classification, monitoring and treatment optimization journals.sagepub.com/doi/10.1177/17โฆ Therapeutic Advances in Gastroenterology Anita Afzali MD, MPH, MHCM, FACG, AGAF Nasim Parsa, M.D. VCU Health VCU Stravitz-Sanyal Institute for Liver Disease

๐จ Pub Alert Raseen Tariq, MD, MS Congrats on a thorough review on #AI impact & opportunities in field of #IBD Let's go! ๐ฅ Take a read and share your thoughts with us ๐๐๐๐ ๐ Therapeutic Advances in Gastroenterology Guest Editor: Nasim Parsa, M.D.


Register for ACGโs Functional GI & Motility Disorders School & Midwest PG Course, ft. Dr. Baharak Moshiree: What Is the Best Treatment for Chronic Idiopathic Constipation? OTCs, FDA-Approved or a Combo of Both? August 22-24 Indianapolis, IN โก๏ธ gi.org/2025midwest Baha Moshiree MD, MSci, FACG, AGAF
